Dr. Southwell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3599 Rainbow Blvd
Kansas City, KS 66160Phone+1 913-588-9900Fax+1 913-588-7637
Education & Training
- University of Kansas School of MedicineFellowship, Clinical Neurophysiology, 2007 - 2008
- University of Kansas School of MedicineResidency, Neurology, 2004 - 2007
- University of Kansas School of MedicineResidency, Internal Medicine, 2003 - 2006
- Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 2003
Certifications & Licensure
- KS State License 2013 - 2025
- MO State License 2021 - 2025
- ID State License 2007 - 2011
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
Publications & Presentations
PubMed
- 11 citationsAcrolein modifies and inhibits cytosolic aspartate aminotransferase.James L Southwell, George S Yeargans, Catherine Kowalewski, Norbert W. Seidler
Journal of Enzyme Inhibition and Medicinal Chemistry. 2002-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: